Dystonia
Resources for Patients and Caregivers
Cluster Number:
Wiki Number: 14-Dystonia-Medication-Induced
Diagnosis:
US Patients:
World Patients:
Sex Ratio:
Age Onset:
Brain Area:
Symptoms: uncontrolled muscle spasms and contractions after antipschotic medicines.
Progression: can become progressively worse
Causes:
Medications:
Therapies: reduce or change medications
Youtube Video: Dystonia-Generalized Dystonia
Amazon or Library Book: Diagnosis Dystonia
Amazon or Library Book:
Living Well with Dystonia
Click the book to link or buy from Amazon.
Click the book to link or buy from Amazon.
Resources for Physicians, Counselors and Researchers
4 CURRENT ARTICLES
FROM PUBMED
The world-wide medical research
reports chosen for each diagnosis
Clicking each title opens the
PubMed article’s summary-abstract.
- Biomarkersby Rebecca Price on January 9, 2025
CONCLUSION: Access to biospecimens is a critical need across all stages of research. The NINDS repositories, BioSEND and NHCDR, provide biofluid and patient-derived cell lines from various neurological disorders, including AD/ADRDs. Both repositories continue to expand available cohorts which are available to researchers worldwide. More information about BioSEND and available cell lines can be found at https://biosend.org/index.html. More information about NHCDR and available cells, including...
- Studying Rare Movement Disorders: From Whole-Exome Sequencing to New Diagnostic and Therapeutic Approaches in a Modern Genetic Clinicby Luca Marsili on January 8, 2025
Background: Rare movement disorders often have a genetic etiology. New technological advances have increased the odds of achieving genetic diagnoses: next-generation sequencing (NGS) (whole-exome sequencing-WES; whole-genome sequencing-WGS) and long-read sequencing (LRS). In 2017, we launched a WES program for patients with rare movement disorders of suspected genetic etiology. We aim to describe the accumulated experience of a modern movement disorder genetic clinic, highlighting how different...
- Evaluation of an Antisense Oligonucleotide Targeting CAG Repeats: A Patient-Customized Therapy Study for Huntington's Diseaseby Sergio Adrian Ocampo-Ortega on January 8, 2025
Huntington's disease is a genetic disorder characterized by progressive neuronal cell damage in some areas of the brain; symptoms are commonly associated with chorea, rigidity and dystonia. The symptoms in Huntington's Disease are caused by a pathological increase in the number of Cytokine-Adenine-Guanine (CAG) repeats on the first exon of the Huntingtin gene, which causes a protein to have an excessive number of glutamine residues; this alteration leads to a change in the protein's conformation...
- Managing Lead Fractures in Deep Brain Stimulation for Movement Disorders: A Decade-Long Case Series from a National Neurosurgical Centreby Chingiz Nurimanov on January 8, 2025
Background: Deep brain stimulation (DBS) is an effective treatment for movement disorders, but its long-term efficacy may be undermined by hardware complications such as lead fractures. These complications increase healthcare costs and necessitate surgical revisions. The frequency, timing, and clinical factors associated with lead fractures remain poorly understood. Objective: This study aimed to determine the incidence, timing, and clinical factors associated with lead fractures in a large...